139 related articles for article (PubMed ID: 1464011)
1. Orthotopic liver transplantation for hepatic GVHD following allogeneic BMT for chronic myeloid leukaemia.
Marks DI; Dousset B; Robson A; Imvrios G; Buckels JA; Elias E; Neuberger JM; Foster C; Batchelor R; Goldman JM
Bone Marrow Transplant; 1992 Nov; 10(5):463-6. PubMed ID: 1464011
[TBL] [Abstract][Full Text] [Related]
2. Unexpected late graft failure 9 months after HLA-identical bone marrow transplant (BMT) for chronic myeloid leukemia (CML): treatment with a second BMT.
Gil-Fernández JJ; Arranz R; Cámara R; Alegre A; Figuera A; Fernández-Rañada JM
Haematologica; 1998 Mar; 83(3):285-7. PubMed ID: 9580418
[TBL] [Abstract][Full Text] [Related]
3. Bullous pemphigoid associated with acute graft-versus-host disease after allogeneic bone marrow transplantation.
Delbaldo C; Rieckhoff-Cantoni L; Helg C; Saurat JH
Bone Marrow Transplant; 1992 Oct; 10(4):377-9. PubMed ID: 1422495
[TBL] [Abstract][Full Text] [Related]
4. Graft-versus-host disease following interferon therapy for relapsed chronic myeloid leukaemia post-allogeneic bone marrow transplantation.
Browett PJ; Nelson J; Tiwari S; Van de Water NS; May S; Palmer SJ
Bone Marrow Transplant; 1994 Oct; 14(4):641-4. PubMed ID: 7858542
[TBL] [Abstract][Full Text] [Related]
5. [Effects and prognostic factors of HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia].
Tong XZ; Li J; Tan EX; Zhang GC; Wu XY; Peng AH; Zheng D; Zou WY; Hong WD; Luo SK
Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):545-8. PubMed ID: 17147125
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow transplantation for chronic myeloid leukemia (CML) from unrelated and sibling donors: single center experience.
Lamparelli T; Van Lint MT; Gualandi F; Occhini D; Barbanti M; Sacchi N; Ficai G; Ghinatti C; Ferrara GB; Delfino L; Pozzi S; Morabito A; Zikos P; Vitale V; Corvo R; Frassoni F; Bacigalupo A
Bone Marrow Transplant; 1997 Dec; 20(12):1057-62. PubMed ID: 9466278
[TBL] [Abstract][Full Text] [Related]
7. Severe isolated acute hepatic graft-versus-host disease with vanishing bile duct syndrome.
Yeh KH; Hsieh HC; Tang JL; Lin MT; Yang CH; Chen YC
Bone Marrow Transplant; 1994 Aug; 14(2):319-21. PubMed ID: 7994249
[TBL] [Abstract][Full Text] [Related]
8. Orthotopic liver transplantation for acute grade IV hepatic graft-versus-host disease following bone marrow transplantation.
Figuera A; Tomás JF; Otero MJ; Moreno E; García I; Fernández-Rañada JM
Am J Hematol; 1996 May; 52(1):68-9. PubMed ID: 8638625
[No Abstract] [Full Text] [Related]
9. Preliminary experience with allogeneic bone marrow transplantation in haematological disorders in India.
Saikia TK; Advani SH; Gopal R; Nair CN; Dinsha KA; Kurkure PA; Swaroop VS; Jagannath P; Sharma S; Rao RS
J Assoc Physicians India; 1990 May; 38(5):332-4. PubMed ID: 2387813
[TBL] [Abstract][Full Text] [Related]
10. Adoptive immunotherapy for relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: equal efficacy of lymphocytes from sibling and matched unrelated donors.
van Rhee F; Savage D; Blackwell J; Orchard K; Dazzi F; Lin F; Chase A; Bungey J; Cross NC; Apperley J; Szydlo R; Goldman JM
Bone Marrow Transplant; 1998 May; 21(10):1055-61. PubMed ID: 9632281
[TBL] [Abstract][Full Text] [Related]
11. Unrelated donor bone marrow transplantation as treatment for chronic myeloid leukemia: the Spanish experience. The Chronic Myeloid Leukemia Subcommittee of the GETH. Grupo Español de Trasplante Hemopoyético.
Carreras E; Tomás JF; Sanz G; Iriondo A; Boqué C; López J; Cabrera R; Sureda A; de Soria VG; Sierra J; Sanz MA; Torres A
Haematologica; 2000 May; 85(5):530-8. PubMed ID: 10800172
[TBL] [Abstract][Full Text] [Related]
12. Allogeneic bone marrow transplantation using unrelated donors: a pilot study of the Canadian Bone Marrow Transplant Group.
Phillips GL; Barnett MJ; Brain MC; Chan KW; Huebsch LB; Klingemann HG; Meharchand J; Reece DE; Rybka WB; Shepherd JD
Bone Marrow Transplant; 1991 Dec; 8(6):477-87. PubMed ID: 1790428
[TBL] [Abstract][Full Text] [Related]
13. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
[TBL] [Abstract][Full Text] [Related]
14. Acute GVHD involving the gastrointestinal tract and infestation with Blastocystis hominis in a patient with chronic myeloid leukaemia following allogeneic bone marrow transplantation.
Ghosh K; Ayyaril M; Nirmala V
Bone Marrow Transplant; 1998 Dec; 22(11):1115-7. PubMed ID: 9877276
[TBL] [Abstract][Full Text] [Related]
15. Role of splenic irradiation in patients with chronic myeloid leukemia undergoing allogeneic bone marrow transplantation.
Jabro G; Koc Y; Boyle T; Schenkein DP; Ravalese J; Wazer D; Miller KB
Biol Blood Marrow Transplant; 1999; 5(3):173-9. PubMed ID: 10392963
[TBL] [Abstract][Full Text] [Related]
16. Low-dose donor CD8+ cells in the CD4-depleted graft prevent allogeneic marrow graft rejection and severe graft-versus-host disease for chronic myeloid leukemia patients in first chronic phase.
Gallardo D; García-López J; Sureda A; Canals C; Ferra C; Cancelas JA; Berlanga JJ; Brunet S; Boqué C; Picón M; Torrico C; Amill B; Martino R; Martínez C; Martín-Henao G; Domingo-Albós A; Grañena A
Bone Marrow Transplant; 1997 Dec; 20(11):945-52. PubMed ID: 9422473
[TBL] [Abstract][Full Text] [Related]
17. Myasthenia gravis after allogeneic bone marrow transplantation.
Shimoda K; Gondo H; Harada M; Sano T; Nakamura M; Otsuka T; Okamura S; Niho Y
Bone Marrow Transplant; 1994 Jul; 14(1):155-6. PubMed ID: 7951105
[TBL] [Abstract][Full Text] [Related]
18. Risk factors in bone marrow transplant recipients with leukaemia. Increased relapse risk in patients treated with ciprofloxacin for gut decontamination.
Carlens S; Ringdén O; Aschan J; Hägglund H; Ljungman P; Mattsson J; Remberger M
Clin Transplant; 1998 Apr; 12(2):84-92. PubMed ID: 9575394
[TBL] [Abstract][Full Text] [Related]
19. Fatal graft-versus-host disease following HLA-mismatched donor lymphocyte infusion.
Amrolia PJ; Rao K; Slater O; Ramsay A; Veys PA; Webb DK
Bone Marrow Transplant; 2001 Sep; 28(6):623-5. PubMed ID: 11607779
[TBL] [Abstract][Full Text] [Related]
20. [Allogeneic skin transplantation in chronic graft-versus-host disease following bone marrow transplantation].
Baumeister RG; Riel KA; Kolb HJ
Chirurg; 1990 Jun; 61(6):438-40. PubMed ID: 2364784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
